Document Detail

Retinaldehyde dehydrogenase 2 is down-regulated during duodenal atresia formation in Fgfr2IIIb-/- mice.
MedLine Citation:
PMID:  21492869     Owner:  NLM     Status:  MEDLINE    
BACKGROUND: Homozygous null mutation of fibroblast growth factor receptor 2 (Fgfr2IIIb) or its ligand fibroblast growth factor 10 (Fgf10) results in duodenal atresia in mice. Mutations of either of these genes in humans cause Matthew-Wood syndrome and associated duodenal stenosis. Recently, mutations in the retinol-binding protein receptor gene STRA6 were reported to be implicated in this syndrome as well. This suggests that the retinoic acid (RA) signaling pathway interacts with the Fgf10-Fgfr2IIIb signaling pathway during duodenal development. Accordingly, we hypothesized that Fgfr2IIIb-/- mouse embryos would exhibit disruptions in expression of Raldh2, the gene for the enzyme that regulates the final step in the conversion of vitamin A to the active form RA, during duodenal atresia formation.
MATERIALS AND METHODS: Fgfr2III -/- mice were generated from heterozygous breedings. Embryos were harvested between embryonic day (E) 11.0 to E 13.5 and genotyped by polymerase chain reaction (PCR). Duodenums were dissected out, fixed and photographed. Whole mount and section in situs were performed for Raldh2.
RESULTS: Fgfr2IIIb-/- embryos demonstrate subtle changes in the duodenal morphology by E11.5 with complete involution of the atretic precursor by E 13.5. Raldh2 appears to be down-regulated as early as E 11.5 in the atretic precursor a full 2 days before this segment disappears.
CONCLUSIONS: In Fgfr2IIIb-/- mouse embryos, a reduction of Raldh2 expression is observed within the region that is forming the atresia. This is the first demonstration of such an event in this model. As in humans, these results implicate disruptions between Fgfr2IIIb receptor function and RA signaling in the formation of this defect and indicate that Fgfr2IIIb-/- mouse embryos are a valid model for the study of the atretic spectrum of defects in human duodenal development.
Peter F Nichol; John D Tyrrell; Yukio Saijoh
Related Documents :
15944199 - Foxl2 is required for commitment to ovary differentiation.
21412779 - Gene expression profiling of pituitary melanotrope cells during their physiological act...
17728319 - Loss of wnt4 and foxl2 leads to female-to-male sex reversal extending to germ cells.
2583479 - A new kind of informational suppression in the nematode caenorhabditis elegans.
18756079 - Plant sex chromosomes.
21966449 - High-throughput analysis of promoter occupancy reveals new targets for arx, a gene muta...
11381139 - Targeted mutation of the murine arylhydrocarbon receptor nuclear translocator 2 (arnt2)...
22961899 - Pleiotropic control of secondary metabolism and morphological development by ksbc, a bu...
9786219 - The murine y1 receptor 5' upstream sequence directs cell-specific and developmentally r...
Publication Detail:
Type:  Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't     Date:  2011-03-21
Journal Detail:
Title:  The Journal of surgical research     Volume:  175     ISSN:  1095-8673     ISO Abbreviation:  J. Surg. Res.     Publication Date:  2012 Jun 
Date Detail:
Created Date:  2012-04-30     Completed Date:  2012-06-26     Revised Date:  2014-09-05    
Medline Journal Info:
Nlm Unique ID:  0376340     Medline TA:  J Surg Res     Country:  United States    
Other Details:
Languages:  eng     Pagination:  82-7     Citation Subset:  IM    
Copyright Information:
Copyright © 2012 Elsevier Inc. All rights reserved.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Aldehyde Oxidoreductases / biosynthesis*,  genetics
Disease Models, Animal
Duodenal Obstruction / congenital,  embryology*,  genetics*
Duodenum / abnormalities,  embryology*,  metabolism*
Mice, Inbred Strains
Receptor, Fibroblast Growth Factor, Type 2 / metabolism*
Sequence Deletion
Signal Transduction / genetics
Tretinoin / metabolism
Vitamin A / metabolism
Grant Support
1K08DK087854/DK/NIDDK NIH HHS; 1R01HD066121-01/HD/NICHD NIH HHS; K08 DK087854/DK/NIDDK NIH HHS; K08 DK087854-01/DK/NIDDK NIH HHS; R01 HD066121/HD/NICHD NIH HHS; R01 HD066121-01/HD/NICHD NIH HHS
Reg. No./Substance:
11103-57-4/Vitamin A; 5688UTC01R/Tretinoin; EC 1.2.-/Aldehyde Oxidoreductases; EC protein, mouse; EC protein, mouse; EC, Fibroblast Growth Factor, Type 2

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Psychomotor Development of Children from an Iodine-Deficient Region.
Next Document:  The Kupffer Cell Inhibition Exacerbates but Splenectomy Prevents Mortality in a Rat Septic Peritonit...